Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis

Conclusion: The 20% lower risk of LTCA (i.e., greater delay) with PIM versus QUE in this analysis may suggest that PIM should be started early for the treatment of PDP.PMID:38099518 | DOI:10.57264/cer-2023-0114

Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Krithika Rajagopalan Nazia Rashid Dilesh Doshi Source Type: research